Literature DB >> 15757964

Leflunomide-induced subacute cutaneous lupus erythematosus.

V Goëb, J M Berthelot, P Joly, O Mejjad, J de Quatrebarbes, C Reynaud-Hautin, O Vittecoq, X Le Loët.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15757964     DOI： 10.1093/rheumatology/keh586

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.

Authors:  J M van Woerkom; A A Kruize; R Geenen; E N van Roon; R Goldschmeding; S M M Verstappen; J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

2.  Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).

Authors:  D Miller Wise
Journal:  Perm J       Date:  2011

3.  Rare Occurrence of Drug Induced Subacute Cutaneous Lupus Erythematosus with Leflunomide Therapy.

Authors:  Harpreet Singh; Gagandeep Sukhija; Vikram Tanwar; Sameer Arora; Jaikrit Bhutani
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 4.  Leflunomide: friend or foe for systemic lupus erythematosus?

Authors:  Guo-Cui Wu; Xiao-Di Xu; Qiong Huang; Hua Wu
Journal:  Rheumatol Int       Date:  2012-09-08       Impact factor: 2.631

5.  Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?

Authors:  Laëtitia Sparsa; Naji Afif; Joëlle Goetz; Christelle Sordet; Emmanuel Chatelus; Dan Lipsker; Jean Sibilia
Journal:  Rheumatol Int       Date:  2009-10-13       Impact factor: 2.631

6.  Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.

Authors:  Meghna Jani; William G Dixon; Lianne Kersley-Fleet; Ian N Bruce; Hector Chinoy; Anne Barton; Mark Lunt; Kath Watson; Deborah P Symmons; Kimme L Hyrich
Journal:  RMD Open       Date:  2017-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.